Please use this identifier to cite or link to this item:
Title: Guidelines for the topical treatment of psoriasis vulgaris in the Levant and Iraq area
Authors: Abbas, Ossama
Ammoury, Alfred
Abbadi, Mohammad
Malek, Medhat Abdel
Akkash, Laith
Al-Chakharah, Kamal
Al-Hamdi, Khalil
Al-Qarqaz, Firas
Al-Soudani, Abduljabbar
Al-Soudani, Nameer
Dandashle, Anwar
El-Sayed, Fouad
Affiliations: Faculty of Medicine 
Issue Date: 2015
Part of: SKINmed
Volume: 13
Issue: 6
Start page: 445
End page: 453
Psoriasis vulgaris is a common chronic, inflammatory, multisystem disorder that affects approximately 1.5% to 3.4% of the population in the Middle East. The disease has an impact on the quality of life in a significant number of affected patients. The majority of patients (approximately 70%) have mild to moderate psoriasis that is manageable with topical agents, which generally show a high efficacy to safety ratio. Topical agents can be used alone when treating patients with limited disease or may be used as adjunctive therapy for patients with more extensive psoriasis undergoing systemic treatment. Treatment should also be customized to meet individual patients’ needs. To optimize the topical treatment of psoriasis in the Levant and Iraq area, dermatology experts from Iraq, Jordan, Lebanon, Palestine, and Syria met and initiated a project to develop guidelines and recommendations for the topical management of psoriasis. The guidelines are based on literature evidence and experts’ opinions. We present recommendations for the use of topical corticosteroids, vitamin D analogues, calcineurin inhibitors, tazarotene, salicylic acid, anthralin, and coal tar, as well as combination therapy, based on their efficacy and safety profiles.
ISSN: 15409740
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

Record view(s)

checked on May 25, 2024

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.